CLSA PREMIUM(06877.HK)料年度淨虧損收窄至5,700萬元
CLSA PREMIUM(06877.HK)預計,截至去年12月31日止年度錄得淨虧損約5,700萬元,2020年度錄得經審覈淨虧損約7,200萬元。
公司指,預期淨虧損減少主要因素包括,總收入減少是由於新西蘭金融市場管理局施加的附加牌照條件導致新西蘭收入下降;集團於2021年年度錄得匯兌淨收益,而2020年年度錄得匯兌淨虧損;從新西蘭稅務局收到與冠狀病毒疫情措施有關的非經常性退稅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.